Centrient Pharmaceuticals Boosting Statins API Manufacturing Capacity

Rotterdam, The Netherlands, June 21 (Bernama-GLOBE NEWSWIRE) —

Summary:

  • Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India.
  • With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins.

http://mrem.bernama.com/viewsm.php?idm=40329

administrator

Related Articles